Artigo Revisado por pares

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

2023; Nature Portfolio; Volume: 29; Issue: 7 Linguagem: Inglês

10.1038/s41591-023-02404-6

ISSN

1546-170X

Autores

Jae H. Park, Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah, Parastoo B. Dahi, Richard J. Lin, Michael Scordo, Miguel‐Angel Perales, Roni Shouval, Ana Alarcón Tomás, Elizabeth Cathcart, Elena Mead, Bianca Santomasso, Andrei I. Holodny, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain,

Tópico(s)

Advancements in Semiconductor Devices and Circuit Design

Referência(s)
Altmetric
PlumX